1. Home
  2. PLAB vs DAWN Comparison

PLAB vs DAWN Comparison

Compare PLAB & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • DAWN
  • Stock Information
  • Founded
  • PLAB 1969
  • DAWN 2018
  • Country
  • PLAB United States
  • DAWN United States
  • Employees
  • PLAB N/A
  • DAWN N/A
  • Industry
  • PLAB Semiconductors
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAB Technology
  • DAWN Health Care
  • Exchange
  • PLAB Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • PLAB 1.4B
  • DAWN 1.2B
  • IPO Year
  • PLAB 1987
  • DAWN 2021
  • Fundamental
  • Price
  • PLAB $20.60
  • DAWN $8.07
  • Analyst Decision
  • PLAB Strong Buy
  • DAWN Strong Buy
  • Analyst Count
  • PLAB 1
  • DAWN 7
  • Target Price
  • PLAB $35.00
  • DAWN $32.29
  • AVG Volume (30 Days)
  • PLAB 730.0K
  • DAWN 1.3M
  • Earning Date
  • PLAB 05-21-2025
  • DAWN 05-05-2025
  • Dividend Yield
  • PLAB N/A
  • DAWN N/A
  • EPS Growth
  • PLAB 5.99
  • DAWN N/A
  • EPS
  • PLAB 2.35
  • DAWN N/A
  • Revenue
  • PLAB $862,750,000.00
  • DAWN $131,161,000.00
  • Revenue This Year
  • PLAB $2.84
  • DAWN $28.72
  • Revenue Next Year
  • PLAB $7.54
  • DAWN $73.78
  • P/E Ratio
  • PLAB $8.77
  • DAWN N/A
  • Revenue Growth
  • PLAB N/A
  • DAWN N/A
  • 52 Week Low
  • PLAB $19.61
  • DAWN $7.88
  • 52 Week High
  • PLAB $31.60
  • DAWN $18.07
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 40.50
  • DAWN 36.05
  • Support Level
  • PLAB $20.63
  • DAWN $7.93
  • Resistance Level
  • PLAB $21.80
  • DAWN $8.44
  • Average True Range (ATR)
  • PLAB 0.55
  • DAWN 0.44
  • MACD
  • PLAB 0.06
  • DAWN 0.09
  • Stochastic Oscillator
  • PLAB 11.81
  • DAWN 17.59

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue worldwide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.

Share on Social Networks: